SMTL ID : 3rjm.1

CASPASE2 IN COMPLEX WITH CHDI LIGAND 33c

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.55 Å

Oligo State

hetero-2-2-mer

Ligands

2 x ACE- VAL- ASP- VAL- 3PX- ASJ: Peptide inhibitor (ACE)VDV(3PX)D-CHO(Non-covalent)

ACE-VAL-ASP-VAL-3PX-ASJ.1: 18 residues within 4Å: Chain A: R.55, H.113, Q.154, C.156, D.159, T.161 Chain B: A.29, A.30, M.31, R.32, N.33, T.34, S.38, W.39, G.73, Y.74, A.75, F.80 20 PLIP interactions: 16 interactions with chain B, 4 interactions with chain A Hydrophobic interactions: B:A.30, B:T.34, B:F.80 Hydrogen bonds: B:A.30, B:R.32, B:R.32, B:R.32, B:N.33, B:T.34, B:T.34, B:S.38, B:Y.74, B:Y.74, B:Y.74, A:H.113, A:C.156 Salt bridges: B:R.32, B:R.71, A:R.55, A:H.113 ACE-VAL-ASP-VAL-3PX-ASJ.2: 22 residues within 4Å: Chain C: R.55, S.112, H.113, G.114, Q.154, C.156, D.159, E.160, T.161 Chain D: A.29, A.30, M.31, R.32, N.33, T.34, K.35, W.39, E.72, G.73, Y.74, A.75, F.80 20 PLIP interactions: 4 interactions with chain C, 16 interactions with chain D Hydrogen bonds: C:G.114, C:C.156, D:A.30, D:R.32, D:R.32, D:R.32, D:N.33, D:T.34, D:T.34, D:S.38, D:Y.74, D:Y.74 Salt bridges: C:R.55, C:H.113, D:R.32, D:R.71 Hydrophobic interactions: D:A.30, D:K.35, D:F.80, D:F.80

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Maillard, M.C. et al., Exploiting differences in caspase-2 and -3 S(2) subsites for selectivity: Structure-based design, solid-phase synthesis and in vitro activity of novel substrate-based caspase-2 inhibitors. Bioorg.Med.Chem. (2011)

Release Date

2011-09-21

Peptides

Caspase-2: AC
Caspase-2: BD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

C
C

B
B

D
D

Caspase-2

Caspase-2